These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 19014850)
1. Lucasti et al in the May 2008 issue of Clinical Therapeutics. Porath AD Clin Ther; 2008 Oct; 30(10):1934; author reply 1934-6. PubMed ID: 19014850 [No Abstract] [Full Text] [Related]
2. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study. Lucasti C; Jasovich A; Umeh O; Jiang J; Kaniga K; Friedland I Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934 [TBL] [Abstract][Full Text] [Related]
5. Meropenem monotherapy is as effective as and safer than imipenem to treat brain abscesses. Martin-Canal G; Saavedra A; Asensi JM; Suarez-Zarracina T; Rodriguez-Guardado A; Bustillo E; Fierer J; Carton JA; Collazos J; Asensi V Int J Antimicrob Agents; 2010 Mar; 35(3):301-4. PubMed ID: 20045289 [TBL] [Abstract][Full Text] [Related]
6. Meropenem versus imipenem/cilastatin in intra-abdominal infections requiring surgery. Meropenem Study Group. Geroulanos SJ J Antimicrob Chemother; 1995 Jul; 36 Suppl A():191-205. PubMed ID: 8543495 [TBL] [Abstract][Full Text] [Related]
7. A comparative analysis of meropenem and doripenem in febrile patients with hematologic malignancies: a single-center retrospective study. Toya T; Nannya Y; Narukawa K; Ichikawa M; Kurokawa M Jpn J Infect Dis; 2012; 65(3):228-32. PubMed ID: 22627304 [TBL] [Abstract][Full Text] [Related]
8. The risk of seizures among the carbapenems: a meta-analysis. Cannon JP; Lee TA; Clark NM; Setlak P; Grim SA J Antimicrob Chemother; 2014 Aug; 69(8):2043-55. PubMed ID: 24744302 [TBL] [Abstract][Full Text] [Related]
9. Doripenem: a new carbapenem. Hedge DD S D Med; 2008 Jul; 61(7):260-1. PubMed ID: 18717294 [No Abstract] [Full Text] [Related]
10. The role of carbapenems in the treatment of severe nosocomial respiratory tract infections. Joseph J; Rodvold KA Expert Opin Pharmacother; 2008 Mar; 9(4):561-75. PubMed ID: 18312158 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: a multicenter, randomized study. Chastre J; Wunderink R; Prokocimer P; Lee M; Kaniga K; Friedland I Crit Care Med; 2008 Apr; 36(4):1089-96. PubMed ID: 18379232 [TBL] [Abstract][Full Text] [Related]
13. Doripenem (Doribax)--a new parenteral carbapenem. Med Lett Drugs Ther; 2008 Jan; 50(1278):5-7. PubMed ID: 18219262 [No Abstract] [Full Text] [Related]
14. Efficacy of doripenem in the treatment of Pseudomonas aeruginosa experimental pneumonia versus imipenem and meropenem. Bretonnière C; Jacqueline C; Caillon J; Guitton C; Le Mabecque V; Miégeville AF; Villers D; Potel G; Boutoille D J Antimicrob Chemother; 2010 Nov; 65(11):2423-7. PubMed ID: 20858688 [TBL] [Abstract][Full Text] [Related]
15. Is it safe to use carbapenems in patients with a history of allergy to penicillin? Sodhi M; Axtell SS; Callahan J; Shekar R J Antimicrob Chemother; 2004 Dec; 54(6):1155-7. PubMed ID: 15486083 [TBL] [Abstract][Full Text] [Related]
16. Doripenem: a review of its use in the treatment of bacterial infections. Keam SJ Drugs; 2008; 68(14):2021-57. PubMed ID: 18778123 [TBL] [Abstract][Full Text] [Related]
17. Meropenem versus imipenem/cilastatin in the treatment of intra-abdominal infections. Brismar B; Malmborg AS; Tunevall G; Lindgren V; Bergman L; Mentzing LO; Nyström PO; Anséhn S; Bäckstrand B; Skau T J Antimicrob Chemother; 1995 Jan; 35(1):139-48. PubMed ID: 7768761 [TBL] [Abstract][Full Text] [Related]
18. Intramuscular meropenem in the treatment of bacterial infections of the urinary and lower respiratory tracts. Italian Intramuscular Meropenem Study Group. Romanelli G; Cravarezza P J Antimicrob Chemother; 1995 Jul; 36 Suppl A():109-19. PubMed ID: 8543487 [TBL] [Abstract][Full Text] [Related]
19. Comparison of in vivo nephrotoxicity in the rabbit by a pyrrolidinyl-thio Carbapenem CW-270031. Kim JM; Ha JR; Oh SW; Kim HG; Lee JM; Kim BO; Lee DG; Lee SH; Kim JG J Microbiol Biotechnol; 2008 Nov; 18(11):1768-72. PubMed ID: 19047819 [TBL] [Abstract][Full Text] [Related]
20. Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem. Riera E; Cabot G; Mulet X; García-Castillo M; del Campo R; Juan C; Cantón R; Oliver A J Antimicrob Chemother; 2011 Sep; 66(9):2022-7. PubMed ID: 21653605 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]